Title: Constrained NBMPR analogue synthesis, pharmacophore mapping and 3D-QSAR modeling of equilibrative nucleoside transporter 1 (ENT1) inhibitory activity.
Journal: Bioorganic & medicinal chemistry 20080401
6284-74-8
116035-75-7
1021059-91-5
500283-35-2
100319-01-5
1081148-67-5
1909325-55-8 | 3-[(methylamino)methyl]-1,2,4-oxadiazol-5-ol hydrochloride | AA01C48I | MFCD29763080
1909348-54-4 | tert-butyl 2-{[4-(hydrazinecarbonyl)-1,3-oxazol-5-yl]methoxy}acetate | AA01C4ET | MFCD29906890
1909313-68-3 | N-[(pyrrolidin-3-yl)methyl]acetamide dihydrochloride | AA01C4JG | MFCD29763182
72503-31-2 | 7-chloro-1-methyl-1,2,3,4-tetrahydroquinolin-2-one | AA01C4N4 | MFCD26663830
1500628-77-2 | 1-methyl-1H-1,2,3-benzotriazole-5-sulfonyl chloride | AA01C4T9 | MFCD21145751
1524723-27-0 | 1H-1,2,3,4-tetrazole-5-carbohydrazide | AA01C4XG | MFCD23884265
26395-06-2 | 5-Methyl-2-oxohexanoic acid | AA01C51Y | MFCD19228186
1909293-89-5 | rac-(2R,3S)-2-ethyl-1-methylpyrrolidine-3-carboxylic acid hydrochloride | AA01C55W | MFCD29764241
24068-46-0 | 3-Amino-6,6-dimethylcyclohex-2-enone | AA01C5A7 | MFCD19203859
1188087-56-0 | Methyl 2-(chlorosulfonyl)-4-methylbenzoate | AA01C5EJ | MFCD09746477